Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Aleksandra Walasek"'
Autor:
Bernard H. Bochner, Maria Carlo, Dean F. Bajorin, Michael F. Berger, Zsofia K. Stadler, Mark E. Robson, Kenneth Offit, Irina Ostrovnaya, David B. Solit, Gopakumar V. Iyer, Jonathan E. Rosenberg, Hikmat Al-Ahmadie, Jonathan A. Coleman, Karen A. Cadoo, Michael F. Walsh, Liying Zhang, Yelena Kemel, Diana Mandelker, Michal Wiseman, Manuel R. de Jesus Escano, Hong Truong, Nima Almassi, Timothy Clinton, Emily Bochner, Aleksandra Walasek, Vijai Joseph, Aliya Khurram, Chaitanya Bandlamudi, Preethi Srinivasan, Karissa Whiting, Eugene J. Pietzak
Supplementary Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4064fd0e375df436c79f8f5c894e0e9
https://doi.org/10.1158/1078-0432.22488579.v1
https://doi.org/10.1158/1078-0432.22488579.v1
Autor:
Bernard H. Bochner, Maria Carlo, Dean F. Bajorin, Michael F. Berger, Zsofia K. Stadler, Mark E. Robson, Kenneth Offit, Irina Ostrovnaya, David B. Solit, Gopakumar V. Iyer, Jonathan E. Rosenberg, Hikmat Al-Ahmadie, Jonathan A. Coleman, Karen A. Cadoo, Michael F. Walsh, Liying Zhang, Yelena Kemel, Diana Mandelker, Michal Wiseman, Manuel R. de Jesus Escano, Hong Truong, Nima Almassi, Timothy Clinton, Emily Bochner, Aleksandra Walasek, Vijai Joseph, Aliya Khurram, Chaitanya Bandlamudi, Preethi Srinivasan, Karissa Whiting, Eugene J. Pietzak
Purpose:Identification of inherited germline variants can guide personalized cancer screening, prevention, and treatment. Pathogenic and likely pathogenic (P/LP) germline variants in cancer predisposition genes are frequent among patients with locall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59ebbf4443292e7a701bab0be1872e8f
https://doi.org/10.1158/1078-0432.c.6532764
https://doi.org/10.1158/1078-0432.c.6532764
Autor:
Eugene J. Pietzak, Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph, Aleksandra Walasek, Emily Bochner, Timothy Clinton, Nima Almassi, Hong Truong, Manuel R. de Jesus Escano, Michal Wiseman, Diana Mandelker, Yelena Kemel, Liying Zhang, Michael F. Walsh, Karen A. Cadoo, Jonathan A. Coleman, Hikmat Al-Ahmadie, Jonathan E. Rosenberg, Gopakumar V. Iyer, David B. Solit, Irina Ostrovnaya, Kenneth Offit, Mark E. Robson, Zsofia K. Stadler, Michael F. Berger, Dean F. Bajorin, Maria Carlo, Bernard H. Bochner
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 19
Purpose: Identification of inherited germline variants can guide personalized cancer screening, prevention, and treatment. Pathogenic and likely pathogenic (P/LP) germline variants in cancer predisposition genes are frequent among patients with local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::161a7207e865a8e413a8a9cb88245317
https://escholarship.org/uc/item/4dw9356k
https://escholarship.org/uc/item/4dw9356k
Autor:
Aleksandra Walasek, Dimitar V. Zlatev
Publikováno v:
The Urologic clinics of North America. 49(2)
Cancer immunotherapy has transformed urologic oncology by expanding the arsenal of available treatment options and improving outcomes. The number of patients eligible for immune-based cancer treatment continues to increase as indications for currentl
Autor:
Elyssa Lehman, David A. Foster, Matthew Utter, Suman Mukhopadhyay, Aleksandra Walasek, Deepak Menon, Maria A. Frias
Publikováno v:
J Biol Chem
Mammalian target of rapamycin complex 1 (mTORC1) promotes cell growth and proliferation in response to nutrients and growth factors. Amino acids induce lysosomal translocation of mTORC1 via the Rag GTPases. Growth factors activate Ras homolog enriche
Autor:
Paul Russo, Cihan Duzgol, Alejandro Sanchez, Julian Marcon, Michael W. Kattan, Jonathan A. Coleman, Debra A. Goldman, Roy Mano, Andrew W. Silagy, Maz Ganat, Renzo G. DiNatale, Nicole Benfante, Aleksandra Walasek, Kyle A. Blum, Mahyar Kashan, Irina Ostrovnaya, Oguz Akin, Maria F. Becerra, A. Ari Hakimi
Publikováno v:
Urol Oncol
Objective Recurrent genomic alterations in clear cell renal cell carcinoma (ccRCC) have been associated with treatment outcomes; however, current preoperative predictive models do not include known genetic predictors. We aimed to explore the value of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c365941ec8add831b2ea272abe9e32df
https://europepmc.org/articles/PMC8601021/
https://europepmc.org/articles/PMC8601021/
Publikováno v:
Translational Andrology and Urology. 8:S542-S545
Patients with muscle-invasive bladder cancer (MIBC) have a narrow window of cure that requires aggressive treatment in order to attempt to achieve cure. Guidelines recommend the use of curative intent therapy (CIT) involving radical cystectomy (RC) w
Autor:
Eugene J. Pietzak, Bernard H. Bochner, Hikmat Al-Ahmadie, Dean F. Bajorin, David B. Solit, Gopa Iyer, Jonathan E. Rosenberg, Aleksandra Walasek
Publikováno v:
Translational Cancer Research
We would like to thank Drs. Szarvas, Olah, and Reis for their thoughtful and insightful comments regarding our recent publication on patients who initially present with muscle-invasive bladder cancer (“primary” MIBC) compared to patients with non
Publikováno v:
Urology. 134:42-44
Autor:
Hikmat Al-Ahmadie, Jessica A. Lavery, Michal Wiseman, Guido Dalbagni, Bernard H. Bochner, Nikolaus Schultz, Michael F. Berger, Gopa Iyer, Aditya Bagrodia, Aleksandra Walasek, Eugene J. Pietzak, Nima Almassi, David B. Solit, Victor McPherson, Shweta S. Chavan, Irina Osyrovnaya, Shawn Dason, Timothy Clinton
Publikováno v:
The Journal of Urology. 203:e263-e264
INTRODUCTION AND OBJECTIVE:High-grade non-muscle invasive bladder cancer (NMIBC) is treated with intravesical BCG immunotherapy. Unfortunately, 40% of patients develop recurrence with a subset prog...